CCL2 antibody

Catalog No. ABIN199400

The Mouse Monoclonal anti-CCL2 antibody is suitable to detect CCL2 in samples from Human. It has been validated for ELISA and Neut.

Quick Overview for CCL2 antibody (ABIN199400)

Target: CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CCL2 antibody is un-conjugated

Application: ELISA, Neutralization (Neut)

Clone: S8

Product Details anti-CCL2 Antibody

Specificity: Natural and recombinant human MCP-1. Does not react with human interleukin-8 (IL-8) and other human cytokines tested such as interleukin-1B (IL-1B), serum amyloid A (SAA) and epidermal growth factor (EGF).

Purification: Protein G purified

Immunogen: Purified recombinant human MCP-1.

Isotype: IgG1 kappa

Application Details

Application Notes: Approved: ELISA, Neut

Usage: Suitable for use in ELISA and Neutralization. Neutralizing Activity: Tests on the ability to inhibit monocyte chemotaxis toward 1 nM recombinant human MCP-1 in blindwell chambers showed that this Mab and various others were particularly effective at blocking MCP-1 activity.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: 0.01 M PBS,  pH 7.2

Handling Advice: Avoid repeat freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.

Target Details for CCL2

Target: CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

Alternative Name: CCL2 / MCP-1

Background: Name/Gene ID: CCL2
Subfamily: Intercrine beta
Family: Intercrine

Synonyms: CCL2, C-C motif chemokine 2, Chemokine (C-C motif) ligand 2, GDCF-2, HC11, HSMCR30, MCP1, SCYA2, Small-inducible cytokine A2, Monocyte secretory protein JE, MCAF, MCP-1, Monocyte chemotactic protein 1, SMC-CF

Gene ID: 6347

UniProt: P13500

Pathways: Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection